{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:32:35Z","timestamp":1786116755382,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Italian Ministry of University and Research (MUR) PNRR \u2018National Center for Gene Therapy and Drugs based on RNA Technology\u2019","award":["CN00000041 CN3 Spoke #5 \u2018Inflammatory and Infectious Diseases\u2019"],"award-info":[{"award-number":["CN00000041 CN3 Spoke #5 \u2018Inflammatory and Infectious Diseases\u2019"]}]},{"name":"Italian Ministry of University and Research (MUR) PNRR \u2018National Center for Gene Therapy and Drugs based on RNA Technology\u2019","award":["CN00000041 CN3 Spoke #5 \u2018Inflammatory and Infectious Diseases\u2019"],"award-info":[{"award-number":["CN00000041 CN3 Spoke #5 \u2018Inflammatory and Infectious Diseases\u2019"]}]},{"name":"Italian Ministry of University and Research (MUR) PNRR \u2018National Center for Gene Therapy and Drugs based on RNA Technology\u2019","award":["CN00000041 CN3 Spoke #5 \u2018Inflammatory and Infectious Diseases\u2019"],"award-info":[{"award-number":["CN00000041 CN3 Spoke #5 \u2018Inflammatory and Infectious Diseases\u2019"]}]},{"name":"Italian Ministry of Health 'Multidisciplinary and Interregional Hub for Research and Clinical Experimentation To Combat Pandemics and Antibiotic Resistance'","award":["T4-AN-07, PAN-HUB"],"award-info":[{"award-number":["T4-AN-07, PAN-HUB"]}]},{"name":"Italian Ministry of Health 'Multidisciplinary and Interregional Hub for Research and Clinical Experimentation To Combat Pandemics and Antibiotic Resistance'","award":["T4-AN-07, PAN-HUB"],"award-info":[{"award-number":["T4-AN-07, PAN-HUB"]}]},{"name":"Italian Ministry of Health 'Multidisciplinary and Interregional Hub for Research and Clinical Experimentation To Combat Pandemics and Antibiotic Resistance'","award":["T4-AN-07, PAN-HUB"],"award-info":[{"award-number":["T4-AN-07, PAN-HUB"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04720-6","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:06:33Z","timestamp":1786017993000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Twenty-four-month evaluation of the glycemia risk index in adults with type 1 diabetes using advanced hybrid closed-loop systems"],"prefix":"10.1007","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6251-3069","authenticated-orcid":false,"given":"Laura","family":"Nigi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Distefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina Emanuela","family":"Grieco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorica","family":"Cataldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Dotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"issue":"11","key":"4720_CR1","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.2337\/dc21-0770","volume":"44","author":"RD Leslie","year":"2021","unstructured":"R.D. Leslie, C. Evans-Molina, J. Freund-Brown et al., Adult-Onset Type 1 Diabetes: Current Understanding and Challenges. Diabetes Care. 44(11), 2449\u20132456 (2021). https:\/\/doi.org\/10.2337\/dc21-0770","journal-title":"Diabetes Care"},{"issue":"12","key":"4720_CR2","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1007\/s00125-021-05568-3","volume":"64","author":"RIG Holt","year":"2021","unstructured":"R.I.G. Holt, J.H. DeVries, A. Hess-Fischl et al., The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 64(12), 2609\u20132652 (2021). https:\/\/doi.org\/10.1007\/s00125-021-05568-3","journal-title":"Diabetologia"},{"issue":"6","key":"4720_CR3","doi-asserted-by":"publisher","first-page":"104024","DOI":"10.4239\/wjd.v16.i6.104024","volume":"16","author":"BB He","year":"2025","unstructured":"B.B. He, Z.Z. Liu, R.Y. Xu et al., Glycated hemoglobin is not enough: The role of glycemia risk index for glycemic control assessment in type 1 diabetes. World J. Diabetes. 16(6), 104024 (2025). https:\/\/doi.org\/10.4239\/wjd.v16.i6.104024","journal-title":"World J. Diabetes"},{"issue":"8","key":"4720_CR4","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"T. Battelino, T. Danne, R.M. Bergenstal et al., Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. 42(8), 1593\u20131603 (2019). https:\/\/doi.org\/10.2337\/dci19-0028","journal-title":"Diabetes Care"},{"issue":"9","key":"4720_CR5","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1111\/dom.15766","volume":"26","author":"A Rizzi","year":"2024","unstructured":"A. Rizzi, L. Tartaglione, L. Lucaccini Paoli et al., Evaluation of time in tight range and the glycaemia risk index in adults with type 1 diabetes using an advanced hybrid closed loop system: A 1-year real-world assessment. Diabetes Obes. Metab. 26(9), 4078\u20134086 (2024). https:\/\/doi.org\/10.1111\/dom.15766","journal-title":"Diabetes Obes. Metab."},{"key":"4720_CR6","doi-asserted-by":"publisher","first-page":"1388245","DOI":"10.3389\/fendo.2024.1388245","volume":"15","author":"G Bukara-Radujkovic","year":"2024","unstructured":"G. Bukara-Radujkovic, V. Miljkovic, Glycemic variability through the perspective of the glycemia risk index and time in range and their association with glycated hemoglobin A1c in pediatric patients on sensor-augmented pump therapy. Front. Endocrinol. (Lausanne). 15, 1388245 (2024). https:\/\/doi.org\/10.3389\/fendo.2024.1388245","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"10","key":"4720_CR7","doi-asserted-by":"publisher","first-page":"4356","DOI":"10.1210\/jc.2018-02763","volume":"104","author":"VN Shah","year":"2019","unstructured":"V.N. Shah, S.N. DuBose, Z. Li et al., Continuous Glucose Monitoring Profiles in Healthy Nondiabetic Participants: A Multicenter Prospective Study. J. Clin. Endocrinol. Metab. 104(10), 4356\u20134364 (2019). https:\/\/doi.org\/10.1210\/jc.2018-02763","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"4720_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1089\/dia.2023.0380","volume":"26","author":"RW Beck","year":"2024","unstructured":"R.W. Beck, D. Raghinaru, P. Calhoun et al., A Comparison of Continuous Glucose Monitoring-Measured Time-in-Range 70\u2013180\u00a0mg\/dL Versus Time-in-Tight-Range 70\u2013140\u00a0mg\/dL. Diabetes Technol. Ther. 26(3), 151\u2013155 (2024). https:\/\/doi.org\/10.1089\/dia.2023.0380","journal-title":"Diabetes Technol. Ther."},{"issue":"S3","key":"4720_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1089\/dia.2023.0432","volume":"26","author":"HK Akturk","year":"2024","unstructured":"H.K. Akturk, T. Battelino, J. Casta\u00f1eda et al., Future of Time-in-Range Goals in the Era of Advanced Hybrid Closed-Loop Automated Insulin Delivery Systems. Diabetes Technol. Ther. 26(S3), 102\u2013106 (2024). https:\/\/doi.org\/10.1089\/dia.2023.0432","journal-title":"Diabetes Technol. Ther."},{"issue":"5","key":"4720_CR10","doi-asserted-by":"publisher","first-page":"782","DOI":"10.2337\/dci23-0092","volume":"47","author":"V Hamidi","year":"2024","unstructured":"V. Hamidi, J.H. Pettus, Time in Tight Range for Patients With Type 1 Diabetes: The Time Is Now, or Is It Too Soon? Diabetes Care. 47(5), 782\u2013784 (2024). https:\/\/doi.org\/10.2337\/dci23-0092","journal-title":"Diabetes Care"},{"key":"4720_CR11","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1177\/19322968221085273","volume":"17","author":"DC Klonoff","year":"2023","unstructured":"D.C. Klonoff, J. Wang, D. Rodbard et al., A Glycemia Risk Index (GRI) of hypoglycemia and hyperglycemia for continuous glucose monitoring validated by clinician ratings. J. Diabetes Sci. Technol. 17, 1226\u20131242 (2023). https:\/\/doi.org\/10.1177\/19322968221085273","journal-title":"J. Diabetes Sci. Technol."},{"issue":"9","key":"4720_CR12","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1007\/s40618-025-02609-1","volume":"48","author":"P Oriot","year":"2025","unstructured":"P. Oriot, G. Pr\u00e9vost, J.C. Philips et al., Glycemia risk index (GRI): a metric designed to facilitate the interpretation of continuous glucose monitoring data: a narrative review. J. Endocrinol. Invest. 48(9), 1995\u20132000 (2025). https:\/\/doi.org\/10.1007\/s40618-025-02609-1","journal-title":"J. Endocrinol. Invest."},{"issue":"1","key":"4720_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S2213-8587(22)00319-9","volume":"11","author":"T Battelino","year":"2023","unstructured":"T. Battelino, C.M. Alexander, S.A. Amiel et al., Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol. 11(1), 42\u201357 (2023). https:\/\/doi.org\/10.1016\/S2213-8587(22)00319-9","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4720_CR14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1089\/dia.2022.0401","volume":"25","author":"VN Shah","year":"2023","unstructured":"V.N. Shah, C. Sakamoto, L. Pyle, Optimal sampling duration for continuous glucose monitoring for the estimation of glycemia risk index. Diabetes Technol. Ther. 25, 140\u2013142 (2023). https:\/\/doi.org\/10.1089\/dia.2022.0401","journal-title":"Diabetes Technol. Ther."},{"issue":"3","key":"4720_CR15","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s12020-023-03511-7","volume":"82","author":"P P\u00e9rez-L\u00f3pez","year":"2023","unstructured":"P. P\u00e9rez-L\u00f3pez, P. F\u00e9rnandez-Velasco, P. Bahillo-Curieses et al., Impact of glucose variability on the assessment of the glycemia risk index (GRI) and classic glycemic metrics. Endocrine. 82(3), 560\u2013568 (2023). https:\/\/doi.org\/10.1007\/s12020-023-03511-7","journal-title":"Endocrine"},{"issue":"1","key":"4720_CR16","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s12020-024-03846-9","volume":"86","author":"G D\u00edaz-Soto","year":"2024","unstructured":"G. D\u00edaz-Soto, P. P\u00e9rez-L\u00f3pez, P. F\u00e9rnandez-Velasco et al., Quality of life, diabetes-related stress and treatment satisfaction are correlated with glycemia risk index (GRI), time in range and hypoglycemia\/hyperglycemia components in type 1 diabetes. Endocrine. 86(1), 186\u2013193 (2024). https:\/\/doi.org\/10.1007\/s12020-024-03846-9","journal-title":"Endocrine"},{"issue":"2","key":"4720_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.4093\/dmj.2024.0130","volume":"49","author":"W Fan","year":"2025","unstructured":"W. Fan, C. Deng, R. Xu et al., Efficacy and Safety of Automated Insulin Delivery Systems in Patients with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Diabetes Metab. J. 49(2), 235\u2013251 (2025). https:\/\/doi.org\/10.4093\/dmj.2024.0130","journal-title":"Diabetes Metab. J."},{"key":"4720_CR18","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1111\/dom.15208","volume":"25","author":"KE Karakus","year":"2023","unstructured":"K.E. Karakus, V.N. Shah, D. Klonoff et al., Changes in the glycaemia risk index and its association with other continuous glucose monitoring metrics after initiation of an automated insulin delivery system in adults with type 1 diabetes. Diabetes Obes. Metab. 25, 3144\u20133151 (2023). https:\/\/doi.org\/10.1111\/dom.15208","journal-title":"Diabetes Obes. Metab."},{"key":"4720_CR19","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1089\/dia.2023.0264","volume":"25","author":"JY Kim","year":"2023","unstructured":"J.Y. Kim, J.H. Yoo, J.H. Kim, Comparison of Glycemia Risk Index with Time in Range for Assessing Glycemic Quality. Diabetes Technol. Ther. 25, 883\u2013892 (2023). https:\/\/doi.org\/10.1089\/dia.2023.0264","journal-title":"Diabetes Technol. Ther."},{"key":"4720_CR20","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1089\/dia.2023.0040","volume":"25","author":"C Piona","year":"2023","unstructured":"C. Piona, M. Marigliano, C. Roncar\u00e0 et al., Glycemia Risk Index as a Novel Metric to Evaluate the Safety of Glycemic Control in Children and Adolescents with Type 1 Diabetes: An Observational, Multicenter, Real-Life Cohort Study. Diabetes Technol. Ther. 25, 507\u2013512 (2023). https:\/\/doi.org\/10.1089\/dia.2023.0040","journal-title":"Diabetes Technol. Ther."},{"issue":"4","key":"4720_CR21","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1177\/19322968241231307","volume":"18","author":"MH Lee","year":"2024","unstructured":"M.H. Lee, S. Vogrin, T.W. Jones et al., Hybrid Closed-Loop Versus Manual Insulin Delivery in Adults With Type 1 Diabetes: A Post Hoc Analysis Using the Glycemia Risk Index. J. Diabetes Sci. Technol. 18(4), 764\u2013770 (2024). https:\/\/doi.org\/10.1177\/19322968241231307","journal-title":"J. Diabetes Sci. Technol."},{"issue":"1","key":"4720_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/imj.16143","volume":"54","author":"LE Donaldson","year":"2024","unstructured":"L.E. Donaldson, S. Fourlanos, S. Vogrin et al., Automated insulin delivery among adults with type 1 diabetes for up to 2 years: a real-world, multicentre study. Intern. Med. J. 54(1), 121\u2013128 (2024). https:\/\/doi.org\/10.1111\/imj.16143","journal-title":"Intern. Med. J."},{"issue":"2","key":"4720_CR23","doi-asserted-by":"publisher","first-page":"101617","DOI":"10.1016\/j.diabet.2025.101617","volume":"51","author":"S Picard","year":"2025","unstructured":"S. Picard, B. Courbebaisse, J. Dupont et al., Glycemia Risk Index (GRI) and international glucose targets before and 6 months after initiation of hybrid closed loop system in the CIRDIA, a French multisite out-of-hospital center. Diabetes Metab. 51(2), 101617 (2025). https:\/\/doi.org\/10.1016\/j.diabet.2025.101617","journal-title":"Diabetes Metab."},{"key":"4720_CR24","doi-asserted-by":"publisher","unstructured":"S.L. Cichosz, Predicting High Glycemia Risk Index Trajectory in Individuals With Type 1 Diabetes and Long-term Continuously Glucose Monitoring. J. Diabetes Sci. Technol. 2025:19322968251334365. https:\/\/doi.org\/10.1177\/19322968251334365","DOI":"10.1177\/19322968251334365"},{"issue":"4","key":"4720_CR25","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1177\/19322968241247219","volume":"18","author":"K Panfil","year":"2024","unstructured":"K. Panfil, J.M. Redel, C.A. Vandervelden et al., Correlation Between the Glycemia Risk Index and Longitudinal Hemoglobin A1c in Children and Young Adults With Type 1 Diabetes. J. Diabetes Sci. Technol. 18(4), 771\u2013778 (2024). https:\/\/doi.org\/10.1177\/19322968241247219","journal-title":"J. Diabetes Sci. Technol."},{"key":"4720_CR26","doi-asserted-by":"publisher","first-page":"919942","DOI":"10.3389\/fendo.2022.919942","volume":"13","author":"S Templer","year":"2022","unstructured":"S. Templer, Closed-Loop Insulin Delivery Systems: Past, Present, and Future Directions. Front. Endocrinol. (Lausanne). 13, 919942 (2022). https:\/\/doi.org\/10.3389\/fendo.2022.919942","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"3","key":"4720_CR27","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s40618-021-01674-6","volume":"45","author":"Z Fang","year":"2022","unstructured":"Z. Fang, M. Liu, J. Tao et al., Efficacy and safety of closed-loop insulin delivery versus sensor-augmented pump in the treatment of adults with type 1 diabetes: a systematic review and meta-analysis of randomized-controlled trials. J. Endocrinol. Invest. 45(3), 471\u2013481 (2022). https:\/\/doi.org\/10.1007\/s40618-021-01674-6","journal-title":"J. Endocrinol. Invest."},{"issue":"12","key":"4720_CR28","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1007\/s13300-021-01160-5","volume":"12","author":"A Janez","year":"2021","unstructured":"A. Janez, T. Battelino, T. Klupa et al., Hybrid Closed-Loop Systems for the Treatment of Type 1 Diabetes: A Collaborative, Expert Group Position Statement for Clinical Use in Central and Eastern Europe. Diabetes Ther. 12(12), 3107\u20133135 (2021). https:\/\/doi.org\/10.1007\/s13300-021-01160-5","journal-title":"Diabetes Ther."},{"issue":"6","key":"4720_CR29","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.eprac.2021.04.008","volume":"27","author":"G Grunberger","year":"2021","unstructured":"G. Grunberger, J. Sherr, M. Allende et al., American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes Mellitus. Endocr. Pract. 27(6), 505\u2013537 (2021). https:\/\/doi.org\/10.1016\/j.eprac.2021.04.008","journal-title":"Endocr. Pract."},{"issue":"2","key":"4720_CR30","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1177\/19322968221128565","volume":"18","author":"PY Benhamou","year":"2024","unstructured":"P.Y. Benhamou, A. Adenis, Y. Tourki et al., Efficacy of a Hybrid Closed-Loop Solution in Patients With Excessive Time in Hypoglycaemia: A Post Hoc Analysis of Trials With DBLG1 System. J. Diabetes Sci. Technol. 18(2), 372\u2013379 (2024). https:\/\/doi.org\/10.1177\/19322968221128565","journal-title":"J. Diabetes Sci. Technol."},{"issue":"6","key":"4720_CR31","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1089\/dia.2022.0491","volume":"25","author":"F Lombardo","year":"2023","unstructured":"F. Lombardo, S. Passanisi, A. Alibrandi et al., MiniMed 780G Six-Month Use in Children and Adolescents with Type 1 Diabetes: Clinical Targets and Predictors of Optimal Glucose Control. Diabetes Technol. Ther. 25(6), 404\u2013413 (2023). https:\/\/doi.org\/10.1089\/dia.2022.0491","journal-title":"Diabetes Technol. Ther."},{"issue":"6","key":"4720_CR32","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1177\/19322968241245627","volume":"19","author":"MH Lee","year":"2025","unstructured":"M.H. Lee, J. Gooley, V. Obeyesekere et al., Hybrid Closed Loop in Adults With Type 1 Diabetes and Severely Impaired Hypoglycemia Awareness. J. Diabetes Sci. Technol. 19(6), 1578\u20131590 (2025). https:\/\/doi.org\/10.1177\/19322968241245627","journal-title":"J. Diabetes Sci. Technol."},{"issue":"1","key":"4720_CR33","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1186\/s40001-024-01946-w","volume":"29","author":"E Resmini","year":"2024","unstructured":"E. Resmini, E. Zarra, S. Dotti et al., Impact on Glycemia Risk Index and other metrics in type 1 adult patients switching to Advanced Hybrid Closed-Loop systems: a one-year real-life experience. Eur. J. Med. Res. 29(1), 365 (2024). https:\/\/doi.org\/10.1186\/s40001-024-01946-w","journal-title":"Eur. J. Med. Res."},{"issue":"2","key":"4720_CR34","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1111\/dom.16033","volume":"27","author":"Z Zhang","year":"2025","unstructured":"Z. Zhang, Y. Wang, J. Lu et al., Time in tight range: A key metric for optimal glucose control in the era of advanced diabetes technologies and therapeutics. Diabetes Obes. Metab. 27(2), 450\u2013456 (2025). https:\/\/doi.org\/10.1111\/dom.16033","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"4720_CR35","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1177\/19322968231185115","volume":"19","author":"B Bombaci","year":"2025","unstructured":"B. Bombaci, S. Passanisi, M. Valenzise et al., Real-World Performance of First- Versus Second-Generation Automated Insulin Delivery Systems on a Pediatric Population With Type 1 Diabetes: A One-Year Observational Study. J. Diabetes Sci. Technol. 19(1), 98\u2013104 (2025). https:\/\/doi.org\/10.1177\/19322968231185115","journal-title":"J. Diabetes Sci. Technol."},{"issue":"2","key":"4720_CR36","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1089\/dia.2023.0319","volume":"26","author":"L Nigi","year":"2024","unstructured":"L. Nigi, G. Iraci Sareri, D. Cataldo et al., 12-Month Efficacy of Advanced Hybrid Closed-Loop System in Adult Type 1 Diabetes Patients. Diabetes Technol. Ther. 26(2), 130\u2013135 (2024). https:\/\/doi.org\/10.1089\/dia.2023.0319","journal-title":"Diabetes Technol. Ther."},{"issue":"12","key":"4720_CR37","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1007\/s13300-024-01656-w","volume":"15","author":"L Nigi","year":"2024","unstructured":"L. Nigi, M.L.A. Simon Batzibal, D. Cataldo et al., 12-Month Time in Tight Range Improvement with Advanced Hybrid-Closed Loop System in Adults with Type 1 Diabetes. Diabetes Ther. 15(12), 2557\u20132568 (2024). https:\/\/doi.org\/10.1007\/s13300-024-01656-w","journal-title":"Diabetes Ther."},{"issue":"6","key":"4720_CR38","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.2337\/dc23-2311","volume":"47","author":"S Passanisi","year":"2024","unstructured":"S. Passanisi, G. Salzano, B. Bombaci et al., Sustained Effectiveness of an Advanced Hybrid Closed-Loop System in a Cohort of Children and Adolescents With Type 1 Diabetes: A 1-Year Real-World Study. Diabetes Care. 47(6), 1084\u20131091 (2024). https:\/\/doi.org\/10.2337\/dc23-2311","journal-title":"Diabetes Care"},{"issue":"5","key":"4720_CR39","doi-asserted-by":"publisher","first-page":"790","DOI":"10.2337\/dc23-1581","volume":"47","author":"J Casta\u00f1eda","year":"2024","unstructured":"J. Casta\u00f1eda, A. Arrieta, van den T. Heuvel et al., Time in Tight Glucose Range in Type 1 Diabetes: Predictive Factors and Achievable Targets in Real-World Users of the MiniMed\u2122 780G System. Diabetes Care. 47(5), 790\u2013797 (2024). https:\/\/doi.org\/10.2337\/dc23-1581","journal-title":"Diabetes Care"},{"issue":"3","key":"4720_CR40","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1089\/dia.2023.0373","volume":"26","author":"S Passanisi","year":"2024","unstructured":"S. Passanisi, C. Piona, G. Salzano et al., Aiming for the best glycemic control beyond time in range: time in tight range as a new CGM metric in children and adolescents with type 1 diabetes using different treatment modalities. Diabetes Technol. Ther. 26(3), 161\u2013166 (2024). https:\/\/doi.org\/10.1089\/dia.2023.0373","journal-title":"Diabetes Technol. Ther."},{"issue":"3","key":"4720_CR41","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/pedi.12817","volume":"20","author":"J Petersson","year":"2019","unstructured":"J. Petersson, K. \u00c5kesson, F. Sundberg et al., Translating glycated hemoglobin A1c into time spent in glucose target range: A multicenter study. Pediatr. Diabetes. 20(3), 339\u2013344 (2019). https:\/\/doi.org\/10.1111\/pedi.12817","journal-title":"Pediatr. Diabetes"},{"issue":"3","key":"4720_CR42","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1177\/19322968261432498","volume":"20","author":"GE Umpierrez","year":"2026","unstructured":"G.E. Umpierrez, V.N. Shah, V. Brady et al., Integrating the Glycemia Risk Index Into Clinical Practice and Research: A Consensus Report. J. Diabetes Sci. Technol. 20(3), 695\u2013707 (2026). https:\/\/doi.org\/10.1177\/19322968261432498","journal-title":"J. Diabetes Sci. Technol."},{"issue":"10","key":"4720_CR43","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1089\/dia.2023.0112","volume":"25","author":"E Eviz","year":"2023","unstructured":"E. Eviz, G. Yesiltepe Mutlu, K.E. Karakus et al., The Advanced Hybrid Closed Loop Improves Glycemia Risk Index, Continuous Glucose Monitoring Index, and Time in Range in Children with Type 1 Diabetes: Real-World Data from a Single Center Study. Diabetes Technol. Ther. 25(10), 689\u2013696 (2023). https:\/\/doi.org\/10.1089\/dia.2023.0112","journal-title":"Diabetes Technol. Ther."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04720-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04720-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04720-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T12:06:35Z","timestamp":1786017995000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04720-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4720"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04720-6","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"19 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"256"}}